English
简体中文
Total: £ 56.28
Published Date: 2025-06-12 | Pages: 90 | Tables: 97 | Medical Care
The global market for Medical and Aesthetic Polymer Injections was valued at US$ 5413 million in the year 2024 and is projected to reach a revised size of US$ 7279 million by 2031, growing at a CAGR of 4.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical and Aesthetic Polymer Injections competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medical aesthetic polymer injections are a type of medical aesthetic product with biodegradable polymer microspheres (such as poly-L-lactic acid PLLA, polycaprolactone PCL, hydroxyapatite CaHA, etc.) as the main ingredients. They stimulate the body's own collagen regeneration to achieve skin firming, depression filling and anti-aging effects. The core mechanism is that after the microspheres are injected into the dermis or subcutaneous tissue, they trigger a local mild inflammatory response, activate fibroblasts to produce collagen, gradually replace the filling material and repair the tissue structure. For example, PLLA microspheres can maintain their effects for 18-25 months, PCL microspheres can maintain their effects for 1-4 years, and the degradation products are carbon dioxide and water, which are relatively safe. This type of product is different from traditional instant fillers such as hyaluronic acid because it has a longer-lasting effect and achieves natural rejuvenation through endogenous repair.
North American market for Medical and Aesthetic Polymer Injections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medical and Aesthetic Polymer Injections is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Medical and Aesthetic Polymer Injections include Allergan (AbbVie), Galderma, Dermax, Sculptra, REGEN Biotech (Imeik Technology Development), Haohai Biological Technology, Bloomage Biotechnology, Puliyan (Nanjing) Medical Technology, Huadong Medicine, Sihuan Pharmaceutical Holdings Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical and Aesthetic Polymer Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical and Aesthetic Polymer Injections.
The Medical and Aesthetic Polymer Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical and Aesthetic Polymer Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical and Aesthetic Polymer Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Allergan (AbbVie)
Galderma
Dermax
Sculptra
REGEN Biotech (Imeik Technology Development)
Haohai Biological Technology
Bloomage Biotechnology
Puliyan (Nanjing) Medical Technology
Huadong Medicine
Sihuan Pharmaceutical Holdings Group
Shandong Guyuchun Biotechnology
Changchun SinoBiomaterials
Segment by Type
Polylactic Acid (PLA) Injectables
Polycaprolactone (PCL) Injectables
Polyvinyl Alcohol (PVA) Injectables
Others
Segment by Application
General Hospitals
Aesthetic Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical and Aesthetic Polymer Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical and Aesthetic Polymer Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Medical and Aesthetic Polymer Injections Market Overview
1.1 Product Definition
1.2 Medical and Aesthetic Polymer Injections by Type
1.2.1 Global Medical and Aesthetic Polymer Injections Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polylactic Acid (PLA) Injectables
1.2.3 Polycaprolactone (PCL) Injectables
1.2.4 Polyvinyl Alcohol (PVA) Injectables
1.2.5 Others
1.3 Medical and Aesthetic Polymer Injections by Application
1.3.1 Global Medical and Aesthetic Polymer Injections Market Value by Application (2024 VS 2031)
1.3.2 General Hospitals
1.3.3 Aesthetic Clinics
1.3.4 Others
1.4 Global Medical and Aesthetic Polymer Injections Market Size Estimates and Forecasts
1.4.1 Global Medical and Aesthetic Polymer Injections Revenue 2020-2031
1.4.2 Global Medical and Aesthetic Polymer Injections Sales 2020-2031
1.4.3 Global Medical and Aesthetic Polymer Injections Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medical and Aesthetic Polymer Injections Market Competition by Manufacturers
2.1 Global Medical and Aesthetic Polymer Injections Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medical and Aesthetic Polymer Injections Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medical and Aesthetic Polymer Injections Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medical and Aesthetic Polymer Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Product Type & Application
2.7 Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Date of Enter into This Industry
2.8 Global Medical and Aesthetic Polymer Injections Market Competitive Situation and Trends
2.8.1 Global Medical and Aesthetic Polymer Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medical and Aesthetic Polymer Injections Players Market Share by Revenue
2.8.3 Global Medical and Aesthetic Polymer Injections Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical and Aesthetic Polymer Injections Market Scenario by Region
3.1 Global Medical and Aesthetic Polymer Injections Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medical and Aesthetic Polymer Injections Sales by Region: 2020-2031
3.2.1 Global Medical and Aesthetic Polymer Injections Sales by Region: 2020-2025
3.2.2 Global Medical and Aesthetic Polymer Injections Sales by Region: 2026-2031
3.3 Global Medical and Aesthetic Polymer Injections Revenue by Region: 2020-2031
3.3.1 Global Medical and Aesthetic Polymer Injections Revenue by Region: 2020-2025
3.3.2 Global Medical and Aesthetic Polymer Injections Revenue by Region: 2026-2031
3.4 North America Medical and Aesthetic Polymer Injections Market Facts & Figures by Country
3.4.1 North America Medical and Aesthetic Polymer Injections Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medical and Aesthetic Polymer Injections Sales by Country (2020-2031)
3.4.3 North America Medical and Aesthetic Polymer Injections Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical and Aesthetic Polymer Injections Market Facts & Figures by Country
3.5.1 Europe Medical and Aesthetic Polymer Injections Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medical and Aesthetic Polymer Injections Sales by Country (2020-2031)
3.5.3 Europe Medical and Aesthetic Polymer Injections Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical and Aesthetic Polymer Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Medical and Aesthetic Polymer Injections Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medical and Aesthetic Polymer Injections Sales by Region (2020-2031)
3.6.3 Asia Pacific Medical and Aesthetic Polymer Injections Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical and Aesthetic Polymer Injections Market Facts & Figures by Country
3.7.1 Latin America Medical and Aesthetic Polymer Injections Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medical and Aesthetic Polymer Injections Sales by Country (2020-2031)
3.7.3 Latin America Medical and Aesthetic Polymer Injections Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical and Aesthetic Polymer Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical and Aesthetic Polymer Injections Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medical and Aesthetic Polymer Injections Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medical and Aesthetic Polymer Injections Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical and Aesthetic Polymer Injections Sales by Type (2020-2031)
4.1.1 Global Medical and Aesthetic Polymer Injections Sales by Type (2020-2025)
4.1.2 Global Medical and Aesthetic Polymer Injections Sales by Type (2026-2031)
4.1.3 Global Medical and Aesthetic Polymer Injections Sales Market Share by Type (2020-2031)
4.2 Global Medical and Aesthetic Polymer Injections Revenue by Type (2020-2031)
4.2.1 Global Medical and Aesthetic Polymer Injections Revenue by Type (2020-2025)
4.2.2 Global Medical and Aesthetic Polymer Injections Revenue by Type (2026-2031)
4.2.3 Global Medical and Aesthetic Polymer Injections Revenue Market Share by Type (2020-2031)
4.3 Global Medical and Aesthetic Polymer Injections Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medical and Aesthetic Polymer Injections Sales by Application (2020-2031)
5.1.1 Global Medical and Aesthetic Polymer Injections Sales by Application (2020-2025)
5.1.2 Global Medical and Aesthetic Polymer Injections Sales by Application (2026-2031)
5.1.3 Global Medical and Aesthetic Polymer Injections Sales Market Share by Application (2020-2031)
5.2 Global Medical and Aesthetic Polymer Injections Revenue by Application (2020-2031)
5.2.1 Global Medical and Aesthetic Polymer Injections Revenue by Application (2020-2025)
5.2.2 Global Medical and Aesthetic Polymer Injections Revenue by Application (2026-2031)
5.2.3 Global Medical and Aesthetic Polymer Injections Revenue Market Share by Application (2020-2031)
5.3 Global Medical and Aesthetic Polymer Injections Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan (AbbVie)
6.1.1 Allergan (AbbVie) Company Information
6.1.2 Allergan (AbbVie) Description and Business Overview
6.1.3 Allergan (AbbVie) Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan (AbbVie) Medical and Aesthetic Polymer Injections Product Portfolio
6.1.5 Allergan (AbbVie) Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Company Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Galderma Medical and Aesthetic Polymer Injections Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 Dermax
6.3.1 Dermax Company Information
6.3.2 Dermax Description and Business Overview
6.3.3 Dermax Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dermax Medical and Aesthetic Polymer Injections Product Portfolio
6.3.5 Dermax Recent Developments/Updates
6.4 Sculptra
6.4.1 Sculptra Company Information
6.4.2 Sculptra Description and Business Overview
6.4.3 Sculptra Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sculptra Medical and Aesthetic Polymer Injections Product Portfolio
6.4.5 Sculptra Recent Developments/Updates
6.5 REGEN Biotech (Imeik Technology Development)
6.5.1 REGEN Biotech (Imeik Technology Development) Company Information
6.5.2 REGEN Biotech (Imeik Technology Development) Description and Business Overview
6.5.3 REGEN Biotech (Imeik Technology Development) Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.5.4 REGEN Biotech (Imeik Technology Development) Medical and Aesthetic Polymer Injections Product Portfolio
6.5.5 REGEN Biotech (Imeik Technology Development) Recent Developments/Updates
6.6 Haohai Biological Technology
6.6.1 Haohai Biological Technology Company Information
6.6.2 Haohai Biological Technology Description and Business Overview
6.6.3 Haohai Biological Technology Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Haohai Biological Technology Medical and Aesthetic Polymer Injections Product Portfolio
6.6.5 Haohai Biological Technology Recent Developments/Updates
6.7 Bloomage Biotechnology
6.7.1 Bloomage Biotechnology Company Information
6.7.2 Bloomage Biotechnology Description and Business Overview
6.7.3 Bloomage Biotechnology Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bloomage Biotechnology Medical and Aesthetic Polymer Injections Product Portfolio
6.7.5 Bloomage Biotechnology Recent Developments/Updates
6.8 Puliyan (Nanjing) Medical Technology
6.8.1 Puliyan (Nanjing) Medical Technology Company Information
6.8.2 Puliyan (Nanjing) Medical Technology Description and Business Overview
6.8.3 Puliyan (Nanjing) Medical Technology Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Puliyan (Nanjing) Medical Technology Medical and Aesthetic Polymer Injections Product Portfolio
6.8.5 Puliyan (Nanjing) Medical Technology Recent Developments/Updates
6.9 Huadong Medicine
6.9.1 Huadong Medicine Company Information
6.9.2 Huadong Medicine Description and Business Overview
6.9.3 Huadong Medicine Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Huadong Medicine Medical and Aesthetic Polymer Injections Product Portfolio
6.9.5 Huadong Medicine Recent Developments/Updates
6.10 Sihuan Pharmaceutical Holdings Group
6.10.1 Sihuan Pharmaceutical Holdings Group Company Information
6.10.2 Sihuan Pharmaceutical Holdings Group Description and Business Overview
6.10.3 Sihuan Pharmaceutical Holdings Group Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sihuan Pharmaceutical Holdings Group Medical and Aesthetic Polymer Injections Product Portfolio
6.10.5 Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
6.11 Shandong Guyuchun Biotechnology
6.11.1 Shandong Guyuchun Biotechnology Company Information
6.11.2 Shandong Guyuchun Biotechnology Description and Business Overview
6.11.3 Shandong Guyuchun Biotechnology Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Guyuchun Biotechnology Medical and Aesthetic Polymer Injections Product Portfolio
6.11.5 Shandong Guyuchun Biotechnology Recent Developments/Updates
6.12 Changchun SinoBiomaterials
6.12.1 Changchun SinoBiomaterials Company Information
6.12.2 Changchun SinoBiomaterials Description and Business Overview
6.12.3 Changchun SinoBiomaterials Medical and Aesthetic Polymer Injections Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Changchun SinoBiomaterials Medical and Aesthetic Polymer Injections Product Portfolio
6.12.5 Changchun SinoBiomaterials Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical and Aesthetic Polymer Injections Industry Chain Analysis
7.2 Medical and Aesthetic Polymer Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical and Aesthetic Polymer Injections Production Mode & Process Analysis
7.4 Medical and Aesthetic Polymer Injections Sales and Marketing
7.4.1 Medical and Aesthetic Polymer Injections Sales Channels
7.4.2 Medical and Aesthetic Polymer Injections Distributors
7.5 Medical and Aesthetic Polymer Injections Customer Analysis
8 Medical and Aesthetic Polymer Injections Market Dynamics
8.1 Medical and Aesthetic Polymer Injections Industry Trends
8.2 Medical and Aesthetic Polymer Injections Market Drivers
8.3 Medical and Aesthetic Polymer Injections Market Challenges
8.4 Medical and Aesthetic Polymer Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Medical and Aesthetic Polymer Injections Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Medical and Aesthetic Polymer Injections Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Medical and Aesthetic Polymer Injections Market Competitive Situation by Manufacturers in 2024
Table 4. Global Medical and Aesthetic Polymer Injections Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Medical and Aesthetic Polymer Injections Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Medical and Aesthetic Polymer Injections Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Medical and Aesthetic Polymer Injections Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Medical and Aesthetic Polymer Injections Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Medical and Aesthetic Polymer Injections, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Product Type & Application
Table 12. Global Key Manufacturers of Medical and Aesthetic Polymer Injections, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical and Aesthetic Polymer Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical and Aesthetic Polymer Injections as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical and Aesthetic Polymer Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Medical and Aesthetic Polymer Injections Sales by Region (2020-2025) & (K Units)
Table 18. Global Medical and Aesthetic Polymer Injections Sales Market Share by Region (2020-2025)
Table 19. Global Medical and Aesthetic Polymer Injections Sales by Region (2026-2031) & (K Units)
Table 20. Global Medical and Aesthetic Polymer Injections Sales Market Share by Region (2026-2031)
Table 21. Global Medical and Aesthetic Polymer Injections Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Region (2020-2025)
Table 23. Global Medical and Aesthetic Polymer Injections Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Region (2026-2031)
Table 25. North America Medical and Aesthetic Polymer Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Medical and Aesthetic Polymer Injections Sales by Country (2020-2025) & (K Units)
Table 27. North America Medical and Aesthetic Polymer Injections Sales by Country (2026-2031) & (K Units)
Table 28. North America Medical and Aesthetic Polymer Injections Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Medical and Aesthetic Polymer Injections Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Medical and Aesthetic Polymer Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Medical and Aesthetic Polymer Injections Sales by Country (2020-2025) & (K Units)
Table 32. Europe Medical and Aesthetic Polymer Injections Sales by Country (2026-2031) & (K Units)
Table 33. Europe Medical and Aesthetic Polymer Injections Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Medical and Aesthetic Polymer Injections Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Medical and Aesthetic Polymer Injections Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Medical and Aesthetic Polymer Injections Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Medical and Aesthetic Polymer Injections Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Medical and Aesthetic Polymer Injections Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Medical and Aesthetic Polymer Injections Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Medical and Aesthetic Polymer Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Medical and Aesthetic Polymer Injections Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Medical and Aesthetic Polymer Injections Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Medical and Aesthetic Polymer Injections Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Medical and Aesthetic Polymer Injections Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Medical and Aesthetic Polymer Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Medical and Aesthetic Polymer Injections Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Medical and Aesthetic Polymer Injections Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Medical and Aesthetic Polymer Injections Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Medical and Aesthetic Polymer Injections Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Medical and Aesthetic Polymer Injections Sales (K Units) by Type (2020-2025)
Table 51. Global Medical and Aesthetic Polymer Injections Sales (K Units) by Type (2026-2031)
Table 52. Global Medical and Aesthetic Polymer Injections Sales Market Share by Type (2020-2025)
Table 53. Global Medical and Aesthetic Polymer Injections Sales Market Share by Type (2026-2031)
Table 54. Global Medical and Aesthetic Polymer Injections Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Medical and Aesthetic Polymer Injections Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Type (2020-2025)
Table 57. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Type (2026-2031)
Table 58. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Type (2020-2025)
Table 59. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Type (2026-2031)
Table 60. Global Medical and Aesthetic Polymer Injections Sales (K Units) by Application (2020-2025)
Table 61. Global Medical and Aesthetic Polymer Injections Sales (K Units) by Application (2026-2031)
Table 62. Global Medical and Aesthetic Polymer Injections Sales Market Share by Application (2020-2025)
Table 63. Global Medical and Aesthetic Polymer Injections Sales Market Share by Application (2026-2031)
Table 64. Global Medical and Aesthetic Polymer Injections Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Medical and Aesthetic Polymer Injections Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Application (2020-2025)
Table 67. Global Medical and Aesthetic Polymer Injections Revenue Market Share by Application (2026-2031)
Table 68. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Application (2020-2025)
Table 69. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Application (2026-2031)
Table 70. Allergan (AbbVie) Company Information
Table 71. Allergan (AbbVie) Description and Business Overview
Table 72. Allergan (AbbVie) Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Allergan (AbbVie) Medical and Aesthetic Polymer Injections Product
Table 74. Allergan (AbbVie) Recent Developments/Updates
Table 75. Galderma Company Information
Table 76. Galderma Description and Business Overview
Table 77. Galderma Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Galderma Medical and Aesthetic Polymer Injections Product
Table 79. Galderma Recent Developments/Updates
Table 80. Dermax Company Information
Table 81. Dermax Description and Business Overview
Table 82. Dermax Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Dermax Medical and Aesthetic Polymer Injections Product
Table 84. Dermax Recent Developments/Updates
Table 85. Sculptra Company Information
Table 86. Sculptra Description and Business Overview
Table 87. Sculptra Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sculptra Medical and Aesthetic Polymer Injections Product
Table 89. Sculptra Recent Developments/Updates
Table 90. REGEN Biotech (Imeik Technology Development) Company Information
Table 91. REGEN Biotech (Imeik Technology Development) Description and Business Overview
Table 92. REGEN Biotech (Imeik Technology Development) Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. REGEN Biotech (Imeik Technology Development) Medical and Aesthetic Polymer Injections Product
Table 94. REGEN Biotech (Imeik Technology Development) Recent Developments/Updates
Table 95. Haohai Biological Technology Company Information
Table 96. Haohai Biological Technology Description and Business Overview
Table 97. Haohai Biological Technology Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Haohai Biological Technology Medical and Aesthetic Polymer Injections Product
Table 99. Haohai Biological Technology Recent Developments/Updates
Table 100. Bloomage Biotechnology Company Information
Table 101. Bloomage Biotechnology Description and Business Overview
Table 102. Bloomage Biotechnology Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bloomage Biotechnology Medical and Aesthetic Polymer Injections Product
Table 104. Bloomage Biotechnology Recent Developments/Updates
Table 105. Puliyan (Nanjing) Medical Technology Company Information
Table 106. Puliyan (Nanjing) Medical Technology Description and Business Overview
Table 107. Puliyan (Nanjing) Medical Technology Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Puliyan (Nanjing) Medical Technology Medical and Aesthetic Polymer Injections Product
Table 109. Puliyan (Nanjing) Medical Technology Recent Developments/Updates
Table 110. Huadong Medicine Company Information
Table 111. Huadong Medicine Description and Business Overview
Table 112. Huadong Medicine Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Huadong Medicine Medical and Aesthetic Polymer Injections Product
Table 114. Huadong Medicine Recent Developments/Updates
Table 115. Sihuan Pharmaceutical Holdings Group Company Information
Table 116. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 117. Sihuan Pharmaceutical Holdings Group Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sihuan Pharmaceutical Holdings Group Medical and Aesthetic Polymer Injections Product
Table 119. Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
Table 120. Shandong Guyuchun Biotechnology Company Information
Table 121. Shandong Guyuchun Biotechnology Description and Business Overview
Table 122. Shandong Guyuchun Biotechnology Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shandong Guyuchun Biotechnology Medical and Aesthetic Polymer Injections Product
Table 124. Shandong Guyuchun Biotechnology Recent Developments/Updates
Table 125. Changchun SinoBiomaterials Company Information
Table 126. Changchun SinoBiomaterials Description and Business Overview
Table 127. Changchun SinoBiomaterials Medical and Aesthetic Polymer Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Changchun SinoBiomaterials Medical and Aesthetic Polymer Injections Product
Table 129. Changchun SinoBiomaterials Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Medical and Aesthetic Polymer Injections Distributors List
Table 133. Medical and Aesthetic Polymer Injections Customers List
Table 134. Medical and Aesthetic Polymer Injections Market Trends
Table 135. Medical and Aesthetic Polymer Injections Market Drivers
Table 136. Medical and Aesthetic Polymer Injections Market Challenges
Table 137. Medical and Aesthetic Polymer Injections Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical and Aesthetic Polymer Injections
Figure 2. Global Medical and Aesthetic Polymer Injections Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Medical and Aesthetic Polymer Injections Market Share by Type: 2024 & 2031
Figure 4. Polylactic Acid (PLA) Injectables Product Picture
Figure 5. Polycaprolactone (PCL) Injectables Product Picture
Figure 6. Polyvinyl Alcohol (PVA) Injectables Product Picture
Figure 7. Others Product Picture
Figure 8. Global Medical and Aesthetic Polymer Injections Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Medical and Aesthetic Polymer Injections Market Share by Application: 2024 & 2031
Figure 10. General Hospitals
Figure 11. Aesthetic Clinics
Figure 12. Others
Figure 13. Global Medical and Aesthetic Polymer Injections Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Medical and Aesthetic Polymer Injections Market Size (2020-2031) & (US$ Million)
Figure 15. Global Medical and Aesthetic Polymer Injections Sales (2020-2031) & (K Units)
Figure 16. Global Medical and Aesthetic Polymer Injections Average Price (US$/Unit) & (2020-2031)
Figure 17. Medical and Aesthetic Polymer Injections Report Years Considered
Figure 18. Medical and Aesthetic Polymer Injections Sales Share by Manufacturers in 2024
Figure 19. Global Medical and Aesthetic Polymer Injections Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Medical and Aesthetic Polymer Injections Players: Market Share by Revenue in Medical and Aesthetic Polymer Injections in 2024
Figure 21. Medical and Aesthetic Polymer Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Medical and Aesthetic Polymer Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Medical and Aesthetic Polymer Injections Sales Market Share by Country (2020-2031)
Figure 24. North America Medical and Aesthetic Polymer Injections Revenue Market Share by Country (2020-2031)
Figure 25. United States Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Medical and Aesthetic Polymer Injections Sales Market Share by Country (2020-2031)
Figure 28. Europe Medical and Aesthetic Polymer Injections Revenue Market Share by Country (2020-2031)
Figure 29. Germany Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Medical and Aesthetic Polymer Injections Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Medical and Aesthetic Polymer Injections Revenue Market Share by Region (2020-2031)
Figure 36. China Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Medical and Aesthetic Polymer Injections Sales Market Share by Country (2020-2031)
Figure 44. Latin America Medical and Aesthetic Polymer Injections Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Medical and Aesthetic Polymer Injections Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Medical and Aesthetic Polymer Injections Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Medical and Aesthetic Polymer Injections Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Medical and Aesthetic Polymer Injections by Type (2020-2031)
Figure 55. Global Revenue Market Share of Medical and Aesthetic Polymer Injections by Type (2020-2031)
Figure 56. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Medical and Aesthetic Polymer Injections by Application (2020-2031)
Figure 58. Global Revenue Market Share of Medical and Aesthetic Polymer Injections by Application (2020-2031)
Figure 59. Global Medical and Aesthetic Polymer Injections Price (US$/Unit) by Application (2020-2031)
Figure 60. Medical and Aesthetic Polymer Injections Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
